Filed: 8/14/2025ACC: 0001104659-25-078025
📋 What this filing means
DCVC OPPORTUNITY FUND II GP, LLC filed this quarterly 13F‑HR report disclosing 2 equity positions with a total reported market value of $115.25M. This filing provides a transparent view of the manager's long equity holdings as of the quarter end.
2
Positions
$115.25M
Total AUM (reported)
6.61M
Total Shares
Allocation by class
COM$95.26M82.7%
CL A$19.99M17.3%
Portfolio Concentration
Top 3$115.25M100.0%
Top 3 weight
100.0%
Top 10 weight
100.0%
Voting Authority Distribution
Total shares with voting rights: 6.61M
Sole
Full voting authority
6.61M
shares
% of voting shares100.0%
Shared
Joint voting authority
0.00
shares
% of voting shares0.0%
None
No voting authority
0.00
shares
% of voting shares0.0%
Investment Discretion (by position count)
Sole2
Shared0
Other0
Dominant voting typeSole · 100.0% of voting shares
Institutional Holdings2
Rows:
Rocket Lab Corp
SOLEShares2.66M
TypeSH
Market value$95.26M
82.65%
Sole
2.66M
Shared
0.00
None
0.00
Recursion Pharmaceuticals, Inc.
SOLEShares3.95M
TypeSH
Market value$19.99M
17.35%
Sole
3.95M
Shared
0.00
None
0.00
| Issuer | Class | Shares | Type | Value / Portfolio % | Voting — Sole | Shared | None |
|---|---|---|---|---|---|---|---|
Rocket Lab CorpSOLE | COM | 2.66M | SH | $95.26M 82.65% | 2.66M | 0.00 | 0.00 |
Recursion Pharmaceuticals, Inc.SOLE | CL A | 3.95M | SH | $19.99M 17.35% | 3.95M | 0.00 | 0.00 |